Several European nations have temporarily suspended administration of the Oxford-AstraZeneca COVID-19 vaccine after reports of blood clotting in some patients. Alain Jocard / AFP via Getty Images Hide caption
Toggle labeling
Alain Jocard / AFP via Getty Images
Several European nations have temporarily suspended the administration of the Oxford-AstraZeneca COVID-19 vaccine after reports of blood clotting in some patients.
Alain Jocard / AFP via Getty Images
Sweden is the newest European country to temporarily suspend administration of a COVID-19 vaccine manufactured by AstraZeneca after reports of abnormal blood clotting in its recipients.
Venezuela on Monday announced According to these reports, the use of the vaccine in the country would not be approved at all.
The Swedish Health Department said As a precautionary measure, she would suspend use of the Oxford-AstraZeneca COVID-19 vaccine early Tuesday until the European Medicines Agency announces its findings from its ongoing investigation into reports of negative side effects in patients. The report is expected in a few days.
The country is now joining several other European nations, including France, Germany, the Netherlands and Ireland, which this week wanted to temporarily suspend administration of the vaccine.
Other European countries such as Italy, Austria, Norway and Denmark have suspended, delayed or restricted the introduction of the vaccine because of similar safety concerns.
The World Health Organization continues to support and promote the use of injection.
The AstraZeneca vaccine, manufactured in collaboration with the University of Oxford, is not approved in the USA. It is widespread in Europe.
